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Introduction
The long pentraxin 3 (PTX3) is a member of the pentrax-
in superfamily, a family of proteins characterized by
a pentameric structure that are highly conserved during
evolution (Garlanda et al., 2005; Bottazzi et al., 2006).
PTX3 plays an important role in resistance against
selected pathogens. It is produced by innate-immunity
cells in response to pro-inflammatory signals and acts as
a predecessor of antibodies, regulates complement activa-
tion, facilitates pathogen recognition by phagocytes and
directly recognizes some selected fungal and bacterial
microorganisms such as Aspergillus fumigatus, Pseudomo-
nas aeruginosa and Salmonella typhymurium (Garlanda
et al., 2005; Bottazzi et al., 2006). PTX3 also binds apop-
totic cells (Rovere et al., 2000) and may contribute to
editing recognition of apoptotic cells vs. infectious non-
self (Baruah et al., 2006). In addition, there is evidence
for a regulatory role of PTX3 in non-infectious
inflammatory reactions (Souza et al., 2002; Salio et al.,
unpublished data). In humans, increased levels of PTX3
are found in different infectious diseases (Muller et al.,
2001; Mairuhu et al., 2005), in some autoimmune disor-
ders (Luchetti et al., 2000; Fazzini et al., 2001) and in
inflammatory conditions, reflecting in particular the
involvement of the vascular bed (Latini et al., 2004).
Although PTX3 was initially identified as a molecular
component of the immunological network, more recent
evidence has demonstrated that it also plays a crucial and
non-redundant role in female fertility. Data in mice
revealed that PTX3 deficiency is associated to female
infertility and that this defect is a result of an abnormal
cumulus oophorus characterized by an unstable extracel-
lular matrix in which cumulus cells are dispersed instead
of radiating out from a central oocyte (Varani et al.,
2002; Salustri et al., 2004). More specifically, PTX3 is pro-
duced by cumulus cells and localizes in the hyaluronic
acid (HA)-rich extracellular matrix of the cumulus oo-
phorus where it plays a pivotal role in the formation and
stabilization of this matrix (Salustri et al., 2004).
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Summary
The long pentraxin 3 (PTX3) is a multifunctional soluble pattern recognition
receptor, involved in several processes ranging from innate resistance and
inflammation to clearance of apoptotic cells and organization of hyaluronic
acid-rich extracellular matrices. PTX3 is also a novel marker in several patho-
logical conditions of infectious, inflammatory, or autoimmune origin. This
study was designed to assess whether PTX3 is expressed in the male reproduc-
tive tract and whether PTX3 interacts with human spermatozoa influencing
their function. Here we show for the first time by immunohistochemistry that
PTX3 is expressed in the male genital tract in perivascular connective tissue, in
endothelial cells, in the interstitium, and in the cytoplasm of prostatic epithelial
glandular cells; PTX3 was detectable in seminal plasma in variable levels, which
correlated with the percentage of normal spermatozoa. Moreover, PTX3 binds
to spermatozoa, in particular with immotile cells, localizing in the neck and in
the subacrosomial region. Finally, recombinant PTX3 did not interfere with
sperm motility.
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Follicular development, oocyte competence, luteinization,
implantation, embryo development and delivery are con-
versely not impaired. Data in human are less abundant
but tend to confirm these findings. Cumulus cells express
PTX3 and PTX3 protein is present in the cumulus matrix
and follicular fluid (Zhang et al., 2005; Paffoni et al.,
2006). Real time polymerase chain reaction (RT-PCR)
data also show higher levels of PTX3 mRNA in cumulus
cells from oocytes, which develop in good quality
embryos, indicating in PTX3 a possible marker for oocyte
quality (Zhang et al., 2005), although this is not the case
for PTX3 protein present in the follicular fluid (Paffoni
et al., 2006).
Having found that PTX3 is an essential component of
the extracellular matrix of the cumulus oophorus, it was
hypothesized that the interaction between the spermato-
zoa and PTX3 may have a role in in vivo fertilization (Sa-
lustri et al., 2004). In line with this hypothesis, Salustri
et al. documented that murine spermatozoa bound solu-
ble PTX3 and that the binding site was localized in the
subacrosomial region (Salustri et al., 2004). The role of
the molecule would be merely confined to the interaction
between the spermatozoa and the egg as PTX3-deficient
male mice were shown to be normally fertile (Varani
et al., 2002; Salustri et al., 2004). Interestingly, yet another
pentraxin is involved in fertility: apexin, a long pentraxin
of guinea pig, is localized in testis, and in particular in
sperm, where it is involved in the acrosomial reaction
(Noland et al., 1994).
Despite experimental evidence in animals suggesting
a role of PTX3 also in spermatozoa function, no data
are available in humans. In order to gain insights into
the involvement of PTX3 in male fertility, we have
designed a study aimed to assess whether PTX3 is
expressed in the male reproductive tract and whether
PTX3 interacts with human spermatozoa influencing
their function.
Materials and methods
Subject
Between April 2005 and January 2006, 86 unselected
patients referring to the Infertility Unit, Fondazione
Ospedale Maggiore Policlinico, Mangiagalli and Regina
Elena were offered to enter the study. They were recruited
at the time of referral for semen evaluation and were
asked to donate the part of their semen, which was not
used for the analysis. A questionnaire regarding the gen-
eral health condition was filled out by each patient at the
time of semen collection in order to exclude patients with
malignancies and ⁄or systemic inflammatory diseases.
Thirteen further healthy fertile donors accepted to donate
a semen sample exclusively for research purposes.
For immunohistochemistry studies on male genital
tract, for each type of tissue we used three organs,
obtained from three different patients. Their mean age
was 61 years (range 26–85). This was a retrospective
study performed on tissues obtained from surgery with-
out inclusion or exclusion criteria. Tissues, which were
morphologically normal and not involved in any patho-
logical conditions were selected for immunohistochemis-
try as described below:
Seminal vesicles were obtained from patients with pros-
tatic carcinoma not involving extraprostatic tissues. Semi-
nal vesicles were not involved in neoplasia; prostatic
tissues were obtained from patients with prostatic hyper-
plasia that was limited to the central area of one lobe. For
immunohistochemistry, we selected the glandular and
stromal components of the uninvolved part of the gland,
mainly the contralateral lobe, testis; testicular Leydig cells
and epididymis were obtained from patients with small
tumours, not exceeding 0.2–0.3 cm in diameter. The
components used for immunohistochemical analysis were
located far from the neoplasia and were morphologically
normal.
All subjects gave a written consent prior to entry into
the study. Approval for the study was granted by the local
Institutional Review Board.
Semen collection
Semen specimens were collected by masturbation after
3–5 days of ejaculatory abstinence. In patients referring for
semen analysis, the sample was analysed according to
World Health Organization (WHO) (1999) guidelines
using Kruger ⁄Tygerberg Strict Criteria form sperm mor-
phology assessment. Part of the semen, which was not used
for the analysis, was centrifuged at 350 g for 10 min at
room temperature to separate them from spermatozoa.
Samples were transferred into cryovials and stored at
)20 C until use. In fertile donors, semen was treated by
standardized swim-up procedure. Briefly, ejaculates were
diluted to 10 mL using Sperm Washing Medium (Irvine
Scientific, Santa Ana, CA, USA), centrifuged at 350 g for
10 min and the supernatant discarded; the pellet was re-
suspended in 5 mL of the same medium and centrifuged
at 350 g for further 10 min. The supernatant was removed
and an aliquot of 1 mL of Sperm Washing Medium was
overlaid over the pellet and incubated at 37 C for at least
30 min. After this period, the upper 0.5 mL was pipetted
into a clean tube and the sperm concentration and motility
were evaluated. This fraction contained >99% progressive
motile spermatozoa while the remaining isolated pellet
contained almost exclusively immotile or non-progressive
motile spermatozoa. Functional evaluation and immuno-
fluorescence analysis were immediately performed.
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Immunohistochemistry
Pattern and site of expression of PTX3 were studied by
immunohistochemistry on male genital tract tissues: tes-
tis, testicular Leydig cells and epididymis (from patients
with testicular neoplasia – seminoma and embryonic car-
cinoma), seminal vesicle (from patients with prostatic aci-
nar carcinoma) and prostate (from patients with prostatic
hyperplasia).
Samples were fixed in neutral buffered formalin and
embedded in paraffin; haematoxylin-eosin stained sections
were examined for histological evaluation. For immunohis-
tochemical analysis, 3 lm paraffin-embedded sections were
cut and mounted on Super-frost slides (Bio-optica, Milan,
Italy); after dewaxing in xylene and rehydrating in ethanol,
the sections were pre-treated in a microwave oven (two
cycles for 3 min each at 800 W, in 0.25 mm ethylenediami-
netetraacetic acid (EDTA)) and incubated for 2 h with
PTX3 affinity-purified rabbit IgG against human PTX3
(250 ng ⁄mL) (Muller et al., 2001). The reactions were
revealed by non-biotin peroxidase detection system
(BioGenex, San Ramon, CA, USA) with 3,3¢ diaminobenzi-
dine freebase as chromogen. Negative controls were
obtained by omission of the primary antibody.
ELISA for PTX3
Seminal plasma sample collection, handling and storage
were carefully standardized. The Sandwich Enzyme-
Linked ImmunoSorbent Assay (ELISA) for PTX3 was per-
formed as previously described (Muller et al., 2001).
Briefly, ELISA plates (96 well; Nunc Immuno Plate, Maxi-
Sorp; Nunc A ⁄ S, Roskilde, Denmark) were coated with
100 ng ⁄well of rat monoclonal anti-PTX3 antibody
(mAb) MNB4 diluted in coating buffer (15 mm carbon-
ate, Na2CO3 + NaHCO3, buffer pH 9.6) and were incu-
bated overnight at 4 C. The plates were washed with
washing buffer (Dulbecco’s phosphate buffered containing
0.05% Tween20) and 300 lL of 5% dry milk were added
to block non-specific binding sites. Fifty lL of recombi-
nant human PTX3 standards (100 pg ⁄mL to 2 ng ⁄mL)
and unknown samples were added in duplicate, and incu-
bated for 2 h at 37 C. After three washes with the wash-
ing buffer, 25 ng ⁄well of biotin-conjugated PTX3 affinity-
purified rabbit IgG were added for 1 h at 37 C. Wells
were extensively washed and incubated with 100 lL of
Streptavidin-peroxidase conjugated to dextran backbone
(AmDex, Copenhagen, Denmark) diluted 1 : 4000 for 1 h
at room temperature. After incubation the plates were
washed four times and 100 lL of TMB chromogen (BD
Pharmingen, San Diego, CA, USA) were added. Absor-
bance values were read at 405 nm in an automatic ELISA
reader. PTX3 levels in seminal plasma were analysed after
addition of EDTA 0.35% final concentration to sample
dilution buffer in order to eliminate interference in the
assay by calcium-dependent factors. The absence of inter-
fering factors in the assay and its specificity were ruled
out by adding known amounts of recombinant PTX3 or
mAb MNB4 to the samples.
Fluorescence-Activated Cell Sorting (FACS) analysis and
confocal analysis
Sperm for binding assay was obtained from three fertile
healthy men as described above. Binding of PTX3 to sper-
matozoa was performed as previously described for fungi
(Garlanda et al., 2002 Nature). In PTX3 binding assay,
spermatozoa were constantly maintained in buffers rich
in non-specific proteins (e.g. albumin). Cells were isolated
through swim-up procedure in sperm washing buffer
containing 5% human albumin, blocked with 5% normal
goat serum and bovine serum albumin (BSA) in phos-
phate buffer saline (PBS). Sperm-associated PTX3 and
binding of recombinant PTX3 were characterized by both
FACS analysis and confocal microscopy using direct bio-
tin-conjugated PTX3 and a PTX3 affinity-purified rabbit
polyclonal Ab. A purified rabbit serum was used as irrele-
vant control. PTX3 binding on spermatozoa was dose-
related in the range of 1–50 lg ⁄mL (data not shown).
After the swim-up selection, cells were separated and
resuspended in 0.2% BSA in PBS (washing buffer and
reagent diluents). To evaluate either the exogenous or
endogenous PTX3 binding, 106 motile or non-motile cells
isolated from the two fractions of the swim up procedure,
were incubated with 10 lg ⁄mL recombinant PTX3 (Bot-
tazzi et al., 1997) or left in reagent diluents, respectively
for 30 min at room temperature. Cells were then fixed
with 1% paraformaldehyde (PFA; Sigma, Milan, Italy)
and incubated for 1 h at room temperature with either
PTX3 affinity-purified rabbit polyclonal Ab (5 lg ⁄mL), a
purified rabbit serum (5 lg ⁄mL), or no Ab, followed by
Alexa Fluor 488 conjugated goat anti-rabbit (Invitrogen-
Molecular Probes, Invitrogen, San Giuliano Milanese,
Italy) as secondary Ab. Fluorescence was analysed using a
FACScan cytofluorometer (BD Biosciences, Erembode-
gem, Belgium) and results are expressed as percentage
and mean fluorescence intensity (MFI) values.
The same protocol was used to evaluate PTX3 localiza-
tion on sperms by confocal microscope analysis. For
DNA detection 1 lg ⁄mL Hoechst 33258 (Molecular
Probes) was used. After staining, cells were seeded on
glass slides and mounted with FluorSave Reagent (Calbio-
chem, Nottingham, UK) and analysed with an Olympus
Fluoview, FV1000, laser scanning confocal microscope.
For confocal analysis of the prostate, tissue preparation
and incubation with PTX3 affinity-purified rabbit IgG
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against human PTX3 were performed as described above
for immunohistochemistry. The reactions were revealed
by Alexa Fluor 488 conjugated goat anti-rabbit (Invitro-
gen-Molecular Probes) as secondary Ab. Images
(1024 · 1024 pixels) were acquired with a 100 · 1.4 NA
Plan-Apochromat oil immersion objective (Olympus,
Hamburg, Germany). Differential interference contrast
(Nomarski technique) was also used.
Motility experiments
Recombinant human PTX3 was purified from Chinese
hamster ovary cells constitutively expressing the protein
as described previously (Bottazzi et al., 1997). Recombi-
nant PTX3 contained <0.125 endotoxin units ⁄mL as
checked by the Limulus amebocyte lysate assay (BioWhit-
taker, Inc., Walkersville, MD, USA).
Fresh spermatozoa obtained from 10 healthy fertile
donors were used. Immediately after swim-up procedure,
for every sperm sample, a 4-well dish was prepared diluting
3 · 106 ⁄mL spermatozoa in Sperm Washing medium con-
taining 0, 10, 30 or 100 lg ⁄mL of recombinant PTX3. At
fixed times, after 10, 30, 120 min and 24 h, 10 lL of sperm
sample with the different concentration of PTX3 were
placed on a clean glass slide and covered with a coverslip of
24 mm · 24 mm. After an equilibration period of 1 min,
the preparation was examined at room temperature, at a
magnification of 400· with a phase-contrast microscope
(Eclipse E200, Nikon, Sesto F., Italy) to assess motility.
To this aim, at least 200 successive spermatozoa were evalu-
ated. Every evaluation was repeated a second time in order
to obtain a mean value of the percentages of motile
spermatozoa.
Statistical analysis
The Social Package for Statistical Science (SPSS 12.0 for
Windows, Chicago, IL, USA) was used. Data were
reported as mean ± SD and ⁄or median (interquartile
range, IQR). Wilcoxon test for k repetitive paired data
was used to compare motility in the presence of increas-
ing doses of PTX3. Spearman coefficients were employed
to evaluate correlations between semen concentration of
PTX3 and semen variables. Wilcoxon test for k indepen-
dent groups was used to evaluate semen concentration of
PTX3 according to categorized semen characteristics.
p < 0.05 was considered statistically significant.
Results
Immunohistochemistry analysis was performed on tissue
sections from pathologic male genital tract, with an im-
munopurified polyclonal antibody anti-PTX3. Tissue dis-
tribution of PTX3 in all the tissues examined in the male
genital tract (testis, epididymis, seminal vesicle and pros-
tate), suggested that PTX3 is expressed in perivascular
connective tissue and, focally, in endothelial cells and in
the interstitium (Fig. 1(a–d)). Moreover, in testis, PTX3
a b c d
e f g
Figure 1 Immunohistochemical analysis of long pentraxin 3 (PTX3) expression in the male genital tract. (a) Epididymis: PTX3 immunoreactivity in
endothelial cells. (b) Seminal vesicle: perivascular pattern of distribution (predominantly around lymphatic vessels). Glands were negative. (c) Testis:
PTX3 immuno-staining in secondary spermatocytes (asterisk) and spermatidis (arrowhead). (d) Leydig cells: weak PTX3 positivity in the cytoplasm
of Leydig cells. (e) Prostate: PTX3 immunoreactivity in prostatic interstitium. 20·. (f) Prostate: focal PTX3 positivity in the cytoplasm of some
epithelial glandular cells and in the inflammatory infiltrate localized in glandular lumen. 40·. (g) Confocal analysis of the prostate: PTX3 positivity
in the cytoplasm of epithelial glandular cells. Cells were stained for PTX3 (green) and for DNA (red). Differential interference contrast (Nomarski
technique) is shown on the right panel.
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was found in secondary spermatocytes and spermatids
(Fig. 1e); a weak immuno-staining was observed in Leydig
cells (Fig. 1f). In prostatic tissues, PTX3 positivity was also
found in the cytoplasm of some epithelial glandular cells;
areas of prostatic hyperplasia and prostatitis were charac-
terized by a high PTX3 expression in the interstitium and
in the inflammatory infiltrate, mainly localized in glandu-
lar lumen (Fig. 1c and d). Confocal analysis of the pros-
tate confirmed PTX3 expression in prostatic epithelial
glandular cells. Immunoreactivity was also observed in
leucocytes and exudates present in the glandular lumen
(Fig. 1g). Negative controls were obtained by omission of
the primary antibody or in the presence of non-immune
purified rabbit serum (not shown).
We then assessed whether PTX3 was detectable in sem-
inal plasma and whether levels correlated with classical
variables of semen function. Distribution of PTX3 con-
centration in 86 semen specimens is illustrated in Fig. 2.
The mean ± SD and the median (IQR) were 1.6 ± 4.2
and 0.7 (0.1–1.6) ng ⁄mL, respectively. The molecule was
undetectable in 14 cases (16%) while levels were above
2 ng ⁄mL (the upper limit reported in serum from healthy
subjects) in 18 specimens (21%) (Muller et al., 2001; Paff-
oni et al., 2006). PTX3 in seminal plasma from 13 fertile
donors was not significantly different from unselected
patients, although a tendency for higher levels was
recorded [the mean ± SD and the median (IQR) were
2.4 ± 5.3 and 0.8 (0.1–2.2) ng ⁄mL, respectively]. As
shown in Fig. 2, levels of the molecule were not normally
distributed. The Skewed index (±SE) and the Kurtosis
index (±SE) were 6.6 ± 0.3 and 49.9 ± 0.5, respectively.
As levels were positively skewed, non-parametric statistics
were used for subsequent analyses.
Infertility diagnoses of the 86 recruited patients were
grouped into three different categories: male infertility
(n = 36), unexplained infertility (n = 36) and others
(n = 14) [tubal infertility (n = 6), endometriosis (n = 3)
and mixed (n = 5]. The median (IQR) levels of PTX3 in
the three groups were 0.6 (0.1–1.5), 0.7 (0.1–2.1) and 1.2
(0.4–1.6) ng ⁄mL, respectively (p = 0.59). Semen charac-
teristics of the specimens are shown in Table 1. The
Spearman coefficients of correlation (q) between semen
concentration of PTX3 and semen volume, spermatozoa
concentration, motility and morphology are also reported
in Table 1. A statistically significant positive correlation
emerged with the percentage of normal spermatozoa
(q = 0.34, p = 0.004). Moreover, levels of PTX3
according to the commonly used cut-off values for the
Figure 2 Distribution of semen concentrations of long pentraxin 3 in
86 specimens. The central value per category is reported in the x axis.
Data were not normally distributed. A positively skewed distribution
was observed. The Skewed index (±SE) and the Kurtosis index (±SE)
were 6.6 ± 0.3 and 49.9 ± 0.5, respectively.
Table 1 Sperm parameters and their correla-
tion with long pentraxin 3 (PTX3) levels
Variable
Semen
Correlation with
PTX3
Meana ± SDb
Mediana
(IQR)c
Spearman
Coeff. p
Volume (mL)d 3.7 ± 1.6 3.4 (2.5–4.5) )0.19 0.08
Sperm concentration (106 ⁄ mL)d 53 ± 39 45 (20–78) + 0.13 0.23
Sperm motilitye (%) 54 ± 15 55 (50–64) + 0.17 0.15
Sperm morphologye (%) 7.9 ± 5.1 8 (3–11) + 0.34 0.004
aValues are in ng ⁄ mL; bSD, Standard Deviation; cIQR: Interquartile Range.
dValues are referred to 86 patients: in this group mean ± SD and the median (IQR) PTX3 levels
were 1.6 ± 4.2 and 0.7 (0.1–1.6) ng ⁄ mL.
ePatients with azoospermia or cryptozoospermia (<1.106 spermatozoa ⁄ mL) were excluded
(n = 13): in this group mean ± SD and the median (IQR) PTX3 levels were 1.5 ± 4.1 and 0.6
(0.1–1.5) ng ⁄ mL.
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above-mentioned sperm variables were evaluated (1999).
Results are shown in Table 2. Again, a statistically signifi-
cant difference emerged only for the percentage of normal
spermatozoa. Specifically, concentration of the molecule
appeared to be significantly lower in patients with severe
teratospermia. No relationship with the presence of path-
ological concentration of round cells (>1.106 ⁄mL) could
be demonstrated (Table 2). A subgroup analysis for
patients with azoospermia (n = 7) was performed. In this
group, the median (IQR) concentration of PTX3 was 0.5
(0.1–1.3) ng ⁄mL. In the remainder of our series, the med-
ian (IQR) concentration was 0.7 (0.1–1.6) ng ⁄mL, thus
not significantly different (p = 0.77). All previous analyses
were repeated considering the total amount of PTX3 per
specimen (calculated as concentration · volume of
semen) rather than the concentration. Results were essen-
tially similar (data not shown).
To address the potential functional role of PTX3 in
male fertility, we studied the interaction between sperma-
tozoa and PTX3. Cytofluorometric and confocal
microscopy analysis were performed on spermatozoa
(Fig. 3). The results obtained with four donors suggest
that PTX3, besides being a soluble component of the
seminal plasma, was also associated to cells, in particular
to immotile or non-progressive motile cells. In our series,
the percentage of PTX3 binding spermatozoa does not
correlate with PTX3 levels in the seminal fluid. As shown
by FACS analysis, PTX3 was not detected on progressive
mobile cells (4.12 ± 2.28%, MFI 49) (Fig. 3a). In con-
trast, PTX3 was associated to 49.43 ± 5.28%
(mean ± SD) immobile spermatozoa, with a MFI of 1.298
(Fig. 3b). Among immobile cells, PTX3 was also associ-
ated to 23.4 ± 8.79% ‘round cells’ (MFI 659) (Fig. 3e).
Cells were also assessed for their ability to bind exoge-
nous recombinant PTX3. As shown in Fig. 3a and b,
PTX3 bound more efficiently to immobile or non-pro-
gressive mobile than to progressive mobile cells
(85.81 ± 8.61%, MFI 17.306 vs. 8.6 ± 2.22%, MFI 418,
respectively). ‘Round cells’ displayed also a strong ability
to bind to exogenous PTX3 (65.60 ± 14.83%, MFI 3483)
(Fig. 3e).
The single-cell analysis performed by confocal micros-
copy confirmed these observations and also suggested that
the binding site for PTX3 in spermatozoa was predomi-
nantly localized in the neck and, to a lesser extent, in the
subacrosomial region (a representative experiment is
shown in Fig. 3b,d and f).
To exclude the presence of PTX3 stored inside sperma-
tozoa, we performed cytofluorometric and microscopic
analyses on permeabilized cells, and ELISA on sperm
lysates, but we failed to detect PTX3 (data not shown).
In order to investigate a possible influence of this bind-
ing on sperm function, we incubated spermatozoa from
10 different healthy fertile donors with PTX3. We tested
the hypothesis that the molecule may have a time- and ⁄or
dose-dependent effect on spermatozoa motility. Data on
the percentage of motile spermatozoa are shown in
Table 3. No significant effect emerged regardless of dura-
tion of incubation and the concentration of PTX3 used.
Discussion
The long pentraxin 3 is a multifunctional soluble pattern
recognition receptor, involved in several processes ranging
from innate resistance to inflammation, from clearance of
apoptotic cells to organization of HA-rich extracellular
Table 2 Long pentraxin 3 (PTX3) levels in normal and pathological
semen
Variable n Mediana (IQR) p
Volume (mL):
<2 8 1.4 (0.0–3.0) 0.82
2–6 68 0.7 (0.1–1.6)
>6 10 0.6 (0.1–1.1)
Sperm concentration (106 ⁄ mL):
<5 14 0.8 (0.3–2.6) 0.40
5–19 16 0.5 (0.0–1.3)
>20 56 0.7 (0.1–1.9)
Sperm motilityb,c (%):
<50 18 0.5 (0.0–1.1) 0.09
>50 55 0.7 (0.2–2.0)
Sperm morphologyb (%):
<5 18 0.2 (0.0–1.0) 0.04
5–13 45 0.8 (0.2–2.0)
>14 10 0.6 (0.3–1.8)
Round cells (106 ⁄ mL):
£1 70 0.7 (0.1–1.6) 0.85
>1 16 0.9 (0.1–1.9)
aValues are ng ⁄ mL. IQR: Interquartile range.
bPatients with azoospermia or cryptozoospermia (<1 · 106 spermato-
zoa ⁄ mL) were excluded (n = 13).
cOnly one pathological group was set as motility was found to be
below 25% only in three patients.
Figure 3 Binding and localization of long pentraxin 3 (PTX3) in sperm cells. (a, c, e) FACS analysis and (b, d, f) confocal microscopy analysis of
endogenous or recombinant (exogenous) PTX3 bound to progressive motile sperms (a, b) (population a in scatter plot), to immotile or non-pro-
gressive sperms (c) (population b in scatter plot) and to round cells (e) (population c in scatter plot). Confocal microscopy shows the binding site
for PTX3 in spermatozoa predominantly localized in the neck. Cells were stained for PTX3 (green) and for DNA (red). Differential interference con-
trast (Nomarski technique) is shown on the right of each confocal analysis picture. Cell separation and PTX3 staining were performed as described
in Material and Methods.
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matrices (Garlanda et al., 2005). Capable of being rapidly
induced in inflammatory conditions, PTX3 is also a novel
marker in several pathological conditions of infectious,
inflammatory, or autoimmune origin (Fazzini et al., 2001;
Muller et al., 2001; Latini et al., 2004). In this study, we
have demonstrated for the first time that PTX3 is
expressed in the male genital tract and is a soluble and
cell-associated component of seminal plasma. Moreover,
we demonstrate that recombinant PTX3 binds human
spermatozoa without interfering with sperm motility.
Tissue distribution of PTX3 in male genital tract sug-
gests that PTX3 is expressed in perivascular connective
tissue (predominantly around lymphatic vessels) of male
accessory glands, and, focally, in endothelial cells and in
the interstitium. Immunoreactivity in prostatic glandular
cells and exudates suggests that the prostate is an impor-
tant source of the PTX3 found in semen. Consistently,
the prostate carcinoma cell line PC3 expresses PTX3
mRNA and protein (C. Garlanda, unpublished) and cells
obtained from benign prostatic hyperplasia secrete PTX3
in basal condition and in particular after pro-inflamma-
tory stimuli (G. Penna, unpublished). Overall, these data
suggest that the male genital tract is a source of PTX3 as
a physiological component of the seminal plasma. More-
over, PTX3 immunoreactivity was increased in inflamma-
tory conditions and involved inflammatory cells and
vessel walls. This pattern of expression is consistent with
what has been observed in other tissues (Cetin et al.,
2006; M. Nebuloni, unpublished), and suggests that PTX3
might be a diagnostic marker of inflammatory conditions
of the male genital tract. It is worth mentioning that in
the present study immunohistochemical localization of
PTX3 was performed on pathological specimens and con-
firmative data using normal ⁄healthy tissue specimens are
needed.
The presence of PTX3 in male reproductive tract was
confirmed in the murine model: RT-PCR was performed
on murine testis, prostate, epididymis, ductus deferens,
coagulation glands and compared to the heart, that even
in normal conditions expresses low levels of PTX3
mRNA. Expression in the testis was low, but in other
tissues PTX3 expression was similar to that observed in
the heart (data not shown).
In this study, we have evaluated whether PTX3 levels
in human semen correlated to classical variables of semen
function. To address this point, we recruited 86 consecu-
tive male patients who were referred to our infertility unit
to undergo a semen analysis and we evaluated levels of
PTX3 in the seminal fluid. The mean and median levels
of the molecule were shown to be comparable to levels
reported in plasma from healthy patients, for whom con-
centration is generally between 1.0 ng ⁄mL and 2.0 ng ⁄mL
(Muller et al., 2001; Paffoni et al., 2006). Surprisingly,
concentration of the molecule was not normally distrib-
uted. Levels were indeed markedly positively skewed. In
some cases, extremely high seminal levels of PTX3 were
documented while in a significant proportion of speci-
mens (16%) the molecule was undetectable. To gain
insights into the possible reasons surrounding this obser-
vation, we evaluated levels of PTX3 in three different
diagnostic groups (male infertility, unexplained infertility
and others). This analysis did not show any significant
result. We then correlated the seminal levels of PTX3 to
classical variables of semen quality. No relationship with
semen concentration, semen motility and the presence of
round cells was observed. Conversely, a modest positive
correlation was documented with sperm morphology
(q = 0.34). Interestingly, immunoreactivity was observed
in testis associated in particular to spermatids and sper-
matocytes, and to a lower extent to Leydig cells. It may
be speculated that PTX3 released in seminiferous tubules
is a marker of a normal spermatogenesis. It is however
unlikely that this release is of biological relevance consid-
ering that, in mice the absence of PTX3 is not associated
with male infertility. Further studies are required to dis-
entangle this issue.
The frequency of diagnostic groups observed in our
series does not reflect proportions usually observed in
infertility units (Evers, 2002). The decision to include
patients consecutively has indeed lead to the inclusion of
a greater proportion of patients with unexplained or male
infertility as this kind of patients are generally prescribed
semen analysis more frequently.
It is noteworthy that PTX3 is typically expressed in
inflammatory conditions and it may be hypothesized that
levels of the molecule might be enhanced in inflammatory
and ⁄or infective conditions such as prostatitis or other
male accessory gland infections. Immunohistochemistry
analyses support this possibility as areas of prostatitis
were characterized by higher PTX3 expression. In order
to clarify possible relationship between PTX3 and diag-
nostic entities, a future prospective and properly designed
study is warranted. In particular, recruited subjects will
Table 3 Sperm motility in the presence of recombinant long pentrax-
in 3 (PTX3)
Time
point Control
PTX3
p10 lg ⁄ mL 30 lg ⁄ mL 100 lg ⁄ mL
10 min 76 (41–85) 76 (52–85) 78 (45–84) 76 (58–81) 0.87
45 min 65 (33–80) 70 (30–77) 55 (37–76) 54 (35–73) 0.78
120 min 41 (15–54) 35 (15–62) 42 (24–58) 42 (10–70) 0.11
24 h 2 (0–10) 2 (0–11) 2 (0–12) 4 (0–8) 0.97
Median (interquartile range) values from 10 different experiments are
reported. Data are expressed as median (interquartile range).
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have to undergo a complete diagnostic evaluation includ-
ing a standardized andrological clinical assessment, a tes-
ticular and transrectal sonography, a Stamey test and
hormonal blood tests. The female partner should also
undergo a complete clinical, hormonal and instrumental
evaluation.
Conversely, PTX3 concentration was not related to the
concentration of seminal round cells whose presence in
the seminal fluid is believed to reflect genital inflamma-
tory conditions (Hochreiter, 2003). A future study aimed
to specifically address this point is required. Of relevance
here is that reliable seminal markers of genital inflamma-
tory conditions are currently lacking (Hochreiter, 2003).
FACS and confocal analysis of endogenous and recom-
binant PTX3 binding to spermatozoa indicate that PTX3
binds spermatozoa, in particular immobile cells and that
the binding site is mainly localized in the neck of the
spermatozoa and in part in the subacrosomial region.
This last observation is partly in contrast with what was
observed in mice, as all murine spermatozoa bound
PTX3, and the binding site was shown exclusively local-
ized in the subacrosomial region (Salustri et al., 2004).
Interspecies differences have thus to be considered to
explain this difference.
The long pentraxin 3 is implicated in the recognition
and clearance of apoptotic cells (Rovere et al., 2000; van
Rossum et al., 2004). Apoptosis occurs in the testis and
in normal spermatogenesis (Muratori et al., 2006). The
finding that PTX3 binds with higher affinity immobile
sperms, compared to progressive mobile sperms opens
the possibility that PTX3 is involved in recognition and
modulation of clearance of apoptotic sperms. The linkage
between PTX3 and clearance of apoptotic spermatozoa
has to be deeply investigated, but in our hypothesis PTX3
could be considered a negative marker of ‘sperm health’
and PTX3-negative spermatozoa could be used to
improve in vitro fertilization results. Sperm motility,
vitality and morphology represent primary criteria for in
vitro sperm selection. In some cases, sperm samples pres-
ent reduced or absent sperm motility and, although at the
moment it is purely theoretical, PTX3-binding could have
an impact in selecting spermatozoa with better fecundity
potential among immotile spermatozoa.
The long pentraxin 3 is also involved in regulating
complement activation and depending on its presence as
soluble or solid phase-associated protein, plays the dual
role of inhibitor or activator of the complement cascade
(Bottazzi et al., 1997; Nauta et al., 2003). Complement is
a major player in innate immunity and is present in the
female genital tract. Spermatozoa must therefore evade
complement attack in the female genital tract.
Complement evasion is achieved by the presence of
complement regulators both in seminal plasma and on
the spermatozoa (Harris et al., 2006). The presence of
PTX3 in normal seminal plasma suggests a potential
involvement as complement modulator.
The long pentraxin 3-deficient female mice are infertile
as a result of a defect in cumulus matrix assembly. Of rel-
evance here is that the oocytes ovulated by PTX3-defi-
cient mice were not fertilized in vivo but could be
fertilized in vitro (Salustri et al., 2004). This observation
supports the crucial role of the normal expansion of the
cumulus in vivo, a role possibly connected with the pres-
ence of a very low number of spermatozoa at the site of
in vivo fertilization. In other words, there is the need for
sperm to be captured and guided to the oocyte (Eisen-
bach & Tur-Kaspa, 1999). It has been suggested that the
binding of PTX3 to the spermatozoa may be a crucial
component of the mechanisms facilitating access of sperm
to the oocyte (Salustri et al., 2004). Even though the pres-
ent study was not useful to clarify this possible role, our
experimental data on the influence of PTX3 on sperm
motility are consistent with this vision. We failed to
observe any effect on motility even at extremely elevated
doses of PTX3 and for longer periods of incubation. The
interaction of PTX3 with the spermatozoa does not thus
influence motility, a crucial function in terms of repro-
ductive competence.
In summary, results from the present study support
the following conclusions: 1) The long pentraxin PTX3 is
expressed in male reproductive tract, at low level in tes-
tis, in epididymis and in seminal vesicles, and at higher
levels in prostate in physiological conditions and particu-
larly in hyperplasia and inflammation. 2) PTX3 is a com-
ponent of the semen, found both in the soluble phase
and the cell-associated phase. 3) Semen concentration of
PTX3 is highly variable and correlates with the percent-
age of normal spermatozoa, but causes surrounding this
variability are unknown and remain to be clarified.
4) Human spermatozoa, in particular immobile cells,
bind PTX3 and the binding site is mainly localized in the
neck and in the subacrosomial region of the spermato-
zoa. 5) Recombinant PTX3 does not interfere with sperm
motility.
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